Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study-Reference-Cited by-同舟云学术

Comparison of efficacy and safety of empagliflozin vs linagliptin added to premixed insulin in patients with uncontrolled type 2 diabetes: A randomized, open-label study

Published:2021-05 Issue:3 Volume:47 Page:101184
ISSN:1262-3636
Container-title:Diabetes & Metabolism
language:en
Short-container-title:Diabetes & Metabolism

Author:

Liu S.-C.,Lee C.-C.,Chuang S.-M.,Sun F.-J.,Zeng Y.-H.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Benefits of timely basal insulin control in patients with type 2 diabetes;Lovre;J Diabetes Complic,2015

2. Practical guidance on the use of premix insulin analogs in initiating, intensifying, or switching insulin regimens in type 2 diabetes;Wu;Diabetes Ther,2015

3. Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial;Tinahones;Diabetes Obes Metab,2014

4. Intensifying insulin regimen after basal insulin optimization in adults with type 2 diabetes: a 24-week, randomized, open-label trial comparing insulin glargine plus insulin glulisine with biphasic insulin aspart (LanScape);Vora;Diabetes Obes Metab,2015

5. Are patients on basal insulin attaining glycemic targets? Characteristics and goal achievement of patients with type 2 diabetes mellitus treated with basal insulin and physician-perceived barriers to achieving glycemic targets;Dalal;Diabetes Res Clin Pract,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus;Journal of Endocrinology and Metabolism;2024-06

2. Risk of Urinary Infections in Veterans on Empagliflozin With Concurrent Catheter Use;Journal of Pharmacy Practice;2024-01-19

3. Effect of empagliflozin versus linagliptin on body composition in Asian patients with type 2 diabetes treated with premixed insulin;Scientific Reports;2022-10-12

4. Glucose-Lowering Agents and the Risk of Hypoglycemia: a Real-world Study;Journal of General Internal Medicine;2022-07-13

5. Development of Metformin Hydrochloride-Linagliptin Controlled Release Tablet Using Hydrophilic Polymers for Type 2 Diabetes in Asians;Polymer Korea;2022-03-31